See also this year's filing and all EDGAR filings for this company.
PDF Report 0001044378_2020_Biocept_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001044378')"} |
Graph
Absolute values for 0001044378, Biocept INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 729,330 |
| 2 | AssetsCurrent | 13,892,597 |
| 3 | PropertyPlantAndEquipment | 1,504,330 |
| 4 | remainder_Assets | 1,606,387 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 5,558,812 |
| 7 | remainder_Liabilities | 973,189 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 10,977,520 |
| 10 | GeneralAndAdministrativeExpense | 6,970,120 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 5,940,843 |
| 15 | ResearchAndDevelopmentExpense | 4,697,022 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 5,528,566 |
| 18 | remainder_NetIncome | -2,081,100 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 17,732,644 |
| 1 | Liabilities | 6,532,001 |
| 2 | Expenses | 28,585,505 |
| 3 | Revenues | 5,528,566 |
| 4 | StockholdersEquity | 11,200,643 |
| 5 | NetIncome | -25,138,039 |
| 6 | ComprehensiveNetIncome | -25,138,039 |
| 7 | BaseVar | 30,229,908 |
| 8 | EconomicCapitalRatio | 0.495 |
Edgar->Model Mapping
Feature Distribution
Change over Time
